RU2218159C2 - ПРИМЕНЕНИЕ α-МЕТИЛ-п-ТИРОЗИНА ДЛЯ ИНГИБИРОВАНИЯ ПРОДУЦИРОВАНИЯ МЕЛАНИНА В МЕЛАНОЦИТАХ РАДУЖНОЙ ОБОЛОЧКИ - Google Patents
ПРИМЕНЕНИЕ α-МЕТИЛ-п-ТИРОЗИНА ДЛЯ ИНГИБИРОВАНИЯ ПРОДУЦИРОВАНИЯ МЕЛАНИНА В МЕЛАНОЦИТАХ РАДУЖНОЙ ОБОЛОЧКИ Download PDFInfo
- Publication number
- RU2218159C2 RU2218159C2 RU99124771/14A RU99124771A RU2218159C2 RU 2218159 C2 RU2218159 C2 RU 2218159C2 RU 99124771/14 A RU99124771/14 A RU 99124771/14A RU 99124771 A RU99124771 A RU 99124771A RU 2218159 C2 RU2218159 C2 RU 2218159C2
- Authority
- RU
- Russia
- Prior art keywords
- melanin
- tyrosine
- pgf
- methyl
- tyrosinase
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT97MI000939A IT1291633B1 (it) | 1997-04-22 | 1997-04-22 | Uso dell'alfa-metil-p-tirosina per inibire la produzione di melanina nei melanociti dell'iride |
| ITMI97A000939 | 1997-04-22 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU99124771A RU99124771A (ru) | 2001-09-20 |
| RU2218159C2 true RU2218159C2 (ru) | 2003-12-10 |
Family
ID=11376994
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU99124771/14A RU2218159C2 (ru) | 1997-04-22 | 1998-04-21 | ПРИМЕНЕНИЕ α-МЕТИЛ-п-ТИРОЗИНА ДЛЯ ИНГИБИРОВАНИЯ ПРОДУЦИРОВАНИЯ МЕЛАНИНА В МЕЛАНОЦИТАХ РАДУЖНОЙ ОБОЛОЧКИ |
Country Status (22)
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1350521A (zh) | 1999-03-05 | 2002-05-22 | 宝洁公司 | C16不饱和的fp选择性前列腺素类似物 |
| US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| US9744237B2 (en) * | 2009-01-29 | 2017-08-29 | Kambiz Thomas Moazed | Method and system for effecting changes in pigmented tissue |
| WO2011011065A1 (en) * | 2009-07-22 | 2011-01-27 | Kambiz Thomas Moazed | Method and system for effecting changes in pigmented tissue |
| US20110280909A1 (en) * | 2009-01-29 | 2011-11-17 | Kambiz Thomas Moazed | Method and system for effecting changes in pigmented tissue |
| US10646552B2 (en) | 2012-01-17 | 2020-05-12 | Tyme, Inc. | Pharmaceutical compositions and methods |
| NZ721280A (en) * | 2012-01-17 | 2017-08-25 | Tyme Inc | Pharmaceutical compositions and methods for treating cancer |
| US10272068B2 (en) | 2012-01-17 | 2019-04-30 | Tyme, Inc. | Pharmaceutical compositions and methods |
| US8481498B1 (en) | 2012-01-17 | 2013-07-09 | Steven Hoffman | Pharmaceutical compositions and methods |
| US20130183263A1 (en) | 2012-01-17 | 2013-07-18 | Steven Hoffman | Pharmaceutical compositions and methods |
| US9585841B2 (en) | 2013-10-22 | 2017-03-07 | Tyme, Inc. | Tyrosine derivatives and compositions comprising them |
| US9326962B2 (en) | 2013-10-22 | 2016-05-03 | Steven Hoffman | Compositions and methods for treating intestinal hyperpermeability |
| US9763903B2 (en) | 2013-10-22 | 2017-09-19 | Steven Hoffman | Compositions and methods for treating intestinal hyperpermeability |
| US10813901B2 (en) | 2013-10-22 | 2020-10-27 | Yamo Pharmaceuticals Llc | Compositions and methods for treating autism |
| US10751313B2 (en) | 2013-10-22 | 2020-08-25 | Yamo Pharmaceuticals Llc | Compositions and methods for treating autism |
| ES2738248B2 (es) * | 2018-06-21 | 2023-03-10 | Consejo Superior Investigacion | Uso de inhibidores de la tirosina hidroxilasa para el tratamiento del aneurisma de aorta |
| US12150924B2 (en) | 2018-07-19 | 2024-11-26 | Yamo Pharmaceuticals Llc | Compositions and methods for treating autism |
| BR112021022784A2 (pt) | 2019-05-14 | 2022-03-22 | Tyme Inc | Composições e métodos para tratamento do câncer |
| CN116035151A (zh) * | 2023-01-18 | 2023-05-02 | 云南贝泰妮生物科技集团股份有限公司 | 一种刺梨闪释粉及其制备方法和应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04117313A (ja) * | 1990-09-06 | 1992-04-17 | Kanebo Ltd | 美白化粧料 |
-
1997
- 1997-04-22 IT IT97MI000939A patent/IT1291633B1/it active IP Right Grant
-
1998
- 1998-04-21 SK SK1424-99A patent/SK284255B6/sk unknown
- 1998-04-21 RU RU99124771/14A patent/RU2218159C2/ru not_active IP Right Cessation
- 1998-04-21 PL PL98336386A patent/PL189304B1/pl not_active IP Right Cessation
- 1998-04-21 ES ES98924164T patent/ES2187028T3/es not_active Expired - Lifetime
- 1998-04-21 US US09/403,524 patent/US6359001B1/en not_active Expired - Fee Related
- 1998-04-21 EP EP98924164A patent/EP0977575B1/en not_active Expired - Lifetime
- 1998-04-21 AT AT98924164T patent/ATE227577T1/de not_active IP Right Cessation
- 1998-04-21 IL IL13250398A patent/IL132503A/en not_active IP Right Cessation
- 1998-04-21 DK DK98924164T patent/DK0977575T3/da active
- 1998-04-21 NZ NZ500435A patent/NZ500435A/en unknown
- 1998-04-21 KR KR1019997009782A patent/KR20010020202A/ko not_active Ceased
- 1998-04-21 PT PT98924164T patent/PT977575E/pt unknown
- 1998-04-21 CN CN98804999A patent/CN1255064A/zh active Pending
- 1998-04-21 WO PCT/EP1998/002365 patent/WO1998047515A1/en not_active Application Discontinuation
- 1998-04-21 DE DE69809408T patent/DE69809408T2/de not_active Expired - Fee Related
- 1998-04-21 HU HU0002100A patent/HUP0002100A3/hu unknown
- 1998-04-21 CA CA002287887A patent/CA2287887A1/en not_active Abandoned
- 1998-04-21 AU AU76462/98A patent/AU732046B2/en not_active Ceased
- 1998-04-21 SI SI9830312T patent/SI0977575T1/xx unknown
- 1998-04-21 JP JP54502598A patent/JP2001521540A/ja not_active Withdrawn
-
1999
- 1999-10-21 NO NO995122A patent/NO995122L/no not_active Application Discontinuation
Non-Patent Citations (1)
| Title |
|---|
| РЛС. Энциклопедия лекарств. - М., 2000, с.468. * |
Also Published As
| Publication number | Publication date |
|---|---|
| ES2187028T3 (es) | 2003-05-16 |
| CA2287887A1 (en) | 1998-10-29 |
| EP0977575A1 (en) | 2000-02-09 |
| IL132503A0 (en) | 2001-03-19 |
| SK284255B6 (sk) | 2004-12-01 |
| KR20010020202A (ko) | 2001-03-15 |
| IL132503A (en) | 2004-06-20 |
| JP2001521540A (ja) | 2001-11-06 |
| DK0977575T3 (da) | 2003-03-10 |
| PT977575E (pt) | 2003-03-31 |
| PL336386A1 (en) | 2000-06-19 |
| DE69809408T2 (de) | 2003-07-10 |
| PL189304B1 (pl) | 2005-07-29 |
| HUP0002100A2 (hu) | 2000-11-28 |
| DE69809408D1 (de) | 2002-12-19 |
| HUP0002100A3 (en) | 2003-05-28 |
| IT1291633B1 (it) | 1999-01-11 |
| ITMI970939A1 (it) | 1998-10-22 |
| SI0977575T1 (en) | 2003-04-30 |
| NO995122L (no) | 1999-12-21 |
| ITMI970939A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1997-04-22 |
| NO995122D0 (no) | 1999-10-21 |
| CN1255064A (zh) | 2000-05-31 |
| ATE227577T1 (de) | 2002-11-15 |
| AU732046B2 (en) | 2001-04-12 |
| SK142499A3 (en) | 2000-09-12 |
| WO1998047515A1 (en) | 1998-10-29 |
| EP0977575B1 (en) | 2002-11-13 |
| NZ500435A (en) | 2001-09-28 |
| AU7646298A (en) | 1998-11-13 |
| US6359001B1 (en) | 2002-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2218159C2 (ru) | ПРИМЕНЕНИЕ α-МЕТИЛ-п-ТИРОЗИНА ДЛЯ ИНГИБИРОВАНИЯ ПРОДУЦИРОВАНИЯ МЕЛАНИНА В МЕЛАНОЦИТАХ РАДУЖНОЙ ОБОЛОЧКИ | |
| Rich et al. | The effect of reduced oxygen tension on colony formation of erythropoietic cells in vitro | |
| KR100310499B1 (ko) | 메티오날 또는 말론디알데히드의 세포 내 비율에 영향을 치는 인자를 함유하는 세포소멸 조절 조성물 | |
| JP2000505426A (ja) | 神経細胞機能の維持、その消失の防止又は回復のためのデプレニル化合物の利用 | |
| DRAGO et al. | α-Methyl-p-tyrosine inhibits latanoprost-induced melanogenesis in vitro | |
| US5948800A (en) | Preventive or therapeutic drug for Alzheimer's disease | |
| Bhattacherjee et al. | Inhibition of the ocular effects of sodium arachidonate by anti-inflammatory compounds | |
| EP0946177B1 (en) | METHOD OF INHIBITING BIOSYNTHESIS OF EIf5A | |
| IE921559A1 (en) | Composition and method of treating depigmentation disorders | |
| AU2002364203A1 (en) | Hydroxamic acid and its derivatives as inhibitors of melanocyte tyrosinase for topical skin lighteners | |
| EP0617622A1 (en) | Use of renin inhibitors for the treatment of glaucoma | |
| Karg et al. | Hydrogen peroxide as a mediator of dopac-induced effects on melanoma cells. | |
| US6872751B2 (en) | Composition and method for augmenting or restoring the production of fetal protein in patient in need thereof | |
| HK1027978A (en) | THE USE OF α-METHYL-P-TYROSINE TO INHIBIT MELANDIN PRODUCTION IN IRIS MELANOCYTES | |
| GB2323783A (en) | Inhibitors of farnesyl protein transferase | |
| CZ372099A3 (cs) | Použití alfa-methyl-p-tyrosinu k inhibici produkce melaninu v pigmentových buňkách duhovky | |
| US20160256419A1 (en) | Application of fluoxetine to treatment of depigmentation diseases | |
| VAN WOERT | Effect of phenothiazines on melanoma tyrosinase activity | |
| WO1997042970A1 (en) | Depigmentating agent in the treatment of melasma | |
| WO2017208129A1 (en) | Pharmaceutical composition and method for reducing intraocular pressure | |
| EP0005333A1 (en) | A pharmaceutical composition comprising an amino acid for reducing blood serum prolactin levels | |
| CA1156148A (en) | Process for reducing depression | |
| WO2001028565A1 (fr) | Medicaments contre la proliferation des pigments et des melanocytes | |
| CA1298549C (en) | COMPOSITIONS CONTAINING GOLGI .alpha.-MANNOSIDASE II INHIBITORS | |
| CN119584967A (zh) | 用甘氨酸转运抑制剂治疗肝性卟啉症的组合物和方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20060422 |